EpiStem - Preclinical Development of Novel Therapies to Treat Epithelial Disease

Print


Sensitive efficacy analysis and surrogate assays for patient well-being are tailored to each customer's exact requirements.

 
«Back

Return to Profile


Send an Enquiry to this Company


The details you provide will not be used to send unsolicited emails.
For further information please read our Privacy Policy.




Home
New On This Site
Products & Services
Company A-Z
Industry Projects
White Papers
Jobs & Careers
Press Releases
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area

For every phase of your drug development